![]() |
Cancer Incidence and
|
Age-adjusted Incidence Rates for Specific Sites, Black Females
| Cancer Site | Total Cases |
Rates | ||||
| 1994 | 1995 | 1996 | 1997 | 1998 Prelim. |
||
| All Sites | 10,232 | 334.6 | 351.8 | 327.2 | 356.0 | 364.7 |
| Oral Cavity and Pharynx | 189 | 6.8 | 5.8 | 6.7 | 6.6 | 6.7 |
| Lip | 5 | 0.0 | 0.0 | 0.4 | 0.2 | 0.3 |
| Tongue | 42 | 2.1 | 1.2 | 1.5 | 1.4 | 1.0 |
| Salivary Gland | 26 | 0.7 | 0.8 | 0.9 | 0.9 | 0.8 |
| Floor of Mouth | 17 | 0.5 | 0.5 | 0.3 | 0.6 | 1.0 |
| Gum and Other Mouth | 38 | 1.3 | 1.0 | 1.0 | 1.5 | 1.8 |
| Nasopharynx | 11 | 0.2 | 0.4 | 0.6 | 0.5 | 0.3 |
| Tonsil | 21 | 0.9 | 0.6 | 1.4 | 0.4 | 0.5 |
| Oropharynx | 5 | 0.3 | 0.2 | 0.0 | 0.0 | 0.3 |
| Hypopharynx | 18 | 0.7 | 1.0 | 0.6 | 0.9 | 0.1 |
| Digestive System | 2,273 | 80.3 | 82.1 | 70.8 | 80.8 | 81.9 |
| Esophagus | 119 | 4.3 | 5.3 | 3.7 | 4.9 | 3.4 |
| Stomach | 252 | 7.9 | 9.1 | 7.6 | 8.9 | 9.4 |
| Small Intestine | 39 | 1.9 | 1.3 | 1.4 | 1.3 | 1.2 |
| Colon and Rectum | 1,355 | 47.9 | 47.8 | 42.3 | 48.9 | 48.8 |
| Colon excluding Rectum | 1,047 | 38.4 | 36.6 | 33.1 | 35.9 | 38.1 |
| Rectum and Rectosigmoid Junction | 308 | 9.5 | 11.2 | 9.2 | 13.0 | 10.7 |
| Anus | 31 | 0.7 | 1.4 | 1.0 | 1.7 | 0.6 |
| Liver and Intrahepatic Bile Duct | 64 | 3.0 | 1.9 | 2.3 | 2.0 | 1.5 |
| Liver | 57 | 2.9 | 1.7 | 2.0 | 1.9 | 1.2 |
| Intrahepatic Bile Duct | 7 | 0.1 | 0.2 | 0.3 | 0.2 | 0.3 |
| Gallbladder | 56 | 1.5 | 2.1 | 1.7 | 1.4 | 2.9 |
| Pancreas | 306 | 10.7 | 11.6 | 9.5 | 10.7 | 11.6 |
| Respiratory System | 1,386 | 54.1 | 45.3 | 45.2 | 47.9 | 52.7 |
| Larynx | 72 | 4.1 | 1.7 | 2.2 | 1.6 | 3.2 |
| Lung and Bronchus | 1,287 | 49.3 | 43.0 | 42.0 | 45.0 | 48.7 |
| Bones and Joints | 14 | 0.2 | 0.6 | 0.3 | 0.4 | 0.8 |
| Soft Tissue (Including Heart) | 83 | 2.5 | 2.1 | 3.2 | 3.2 | 2.8 |
| Skin (Excluding Basal and Squamous) | 64 | 1.8 | 1.9 | 1.9 | 1.9 | 2.1 |
| Melanomas of the Skin | 23 | 0.5 | 0.2 | 0.9 | 1.3 | 0.9 |
| Breast (Invasive) | 2,911 | 91.9 | 98.7 | 95.4 | 97.7 | 100.0 |
| in situ (not included in All Sites) | 499 | 11.3 | 17.9 | 16.9 | 17.6 | 19.7 |
| Female Genital System | 1,498 | 44.9 | 53.0 | 46.9 | 52.7 | 50.6 |
| Cervix (Invasive) | 512 | 15.8 | 17.5 | 15.5 | 15.9 | 13.9 |
| Corpus and Uterus, NOS | 550 | 13.3 | 21.4 | 18.8 | 20.9 | 21.4 |
| Corpus | 494 | 13.0 | 19.2 | 16.9 | 18.5 | 19.0 |
| Uterus, NOS | 56 | 0.3 | 2.2 | 1.9 | 2.5 | 2.4 |
| Ovary | 345 | 12.3 | 10.6 | 10.1 | 12.2 | 12.8 |
| Vagina | 24 | 0.9 | 0.9 | 0.8 | 1.2 | 0.5 |
| Vulva | 47 | 1.8 | 2.1 | 1.4 | 1.4 | 1.2 |
| Urinary System | 379 | 10.1 | 11.9 | 12.2 | 16.4 | 14.6 |
| Urinary Bladder (Including in situ) | 170 | 4.7 | 5.0 | 5.9 | 7.3 | 6.5 |
| Kidney and Renal Pelvis | 197 | 4.8 | 6.7 | 5.7 | 8.8 | 7.8 |
| Ureter | 2 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 |
| Eye | 4 | 0.2 | 0.0 | 0.0 | 0.4 | 0.2 |
| Brain and Other Nervous System | 103 | 2.5 | 4.0 | 3.5 | 3.1 | 4.1 |
| Brain | 86 | 2.0 | 3.3 | 3.0 | 2.5 | 3.6 |
| Endocrine System | 146 | 4.6 | 5.1 | 4.0 | 5.2 | 3.7 |
| Thyroid | 129 | 4.3 | 4.9 | 3.4 | 4.5 | 2.8 |
| Lymphomas | 403 | 11.6 | 10.4 | 13.1 | 14.5 | 14.8 |
| Hodgkins Disease | 66 | 1.6 | 1.2 | 3.2 | 1.7 | 2.7 |
| Non-Hodgkins Lymphomas | 337 | 10.1 | 9.2 | 9.9 | 12.8 | 12.1 |
| Multiple Myeloma | 235 | 8.5 | 8.3 | 6.0 | 8.3 | 9.9 |
| Leukemias | 192 | 6.2 | 6.8 | 5.5 | 8.0 | 6.4 |
| Lymphocytic Leukemia | 69 | 2.5 | 2.7 | 1.7 | 2.9 | 2.3 |
| Acute Lymphocytic Leukemia | 27 | 0.7 | 1.1 | 1.0 | 0.7 | 1.2 |
| Chronic Lymphocytic Leukemia | 38 | 1.6 | 1.4 | 0.6 | 2.2 | 0.9 |
| Myeloid Leukemia | 93 | 2.9 | 3.0 | 3.0 | 3.9 | 3.0 |
| Acute Myeloid Leukemia | 52 | 1.3 | 1.6 | 2.3 | 1.8 | 1.7 |
| Chronic Myeloid Leukemia | 34 | 1.4 | 0.8 | 0.7 | 1.9 | 1.0 |
| Monocytic Leukemia | 4 | 0.0 | 0.0 | 0.1 | 0.4 | 0.2 |
| Other Leukemia | 26 | 0.8 | 1.2 | 0.6 | 0.9 | 0.9 |
| Ill-Defined & Unspecified Sites | 352 | 8.6 | 15.7 | 12.5 | 9.2 | 13.5 |
|
|